U.S. stock futures climbed on Monday morning after media accounts indicated Iran had ended military operations against Israel, a development that appeared to soothe investor uncertainty following renewed strikes between the two countries.
By 07:49 ET (11:49 GMT), the Dow futures contract was up about 109 points, or 0.2%. The S&P 500 futures had increased roughly 47 points, or 0.6%, while Nasdaq 100 futures were higher by about 365 points, or 1.3%.
Premarket movers
Among notable premarket action:
- Semiconductors - Chip stocks steadied after a sell-off last week. Broadcom, Micron and Nvidia were all trading higher ahead of the opening bell.
- Airlines - Shares of Southwest Airlines and Delta Air Lines moved around the flatline as a rise in oil prices kept concerns about higher fuel expenses in focus.
- Energy - Major oil producers including Exxon Mobil, Chevron, APA Corp, Devon Energy and Occidental Petroleum showed marginal gains, supported by elevated crude prices.
- Healthcare and biotech - Eli Lilly advanced after trial results showed its next-generation drug helped with weight loss, knee pain and sleep apnea. Nurix Therapeutics shares rose following a $2 billion cancer drug agreement with Roche.
- Consumer goods - Campbell's Co. jumped more than 2% after reiterating its full-year forecast shortly after trimming that outlook earlier in the year.
- Homebuilding - Lennar Corporation hovered below the flatline after BTIG lowered its price target for the company, citing rising land banking costs.
The market snapshot in the early premarket session included a broad mix of modest moves across sectors, with some cyclical and defensive names reacting to company-specific updates and commodity price dynamics.
Implications for sectors
- Semiconductor stocks recovered some ground following last week’s weakness, reflecting cautious investor interest in chip-related names.
- Energy producers saw limited upward momentum as oil prices remained elevated, keeping cost pressures for fuel-intensive industries such as airlines on investors’ radars.
- Selective gains in healthcare and packaged foods were driven by drug trial results, licensing deals and corporate guidance confirmation.
Market participants continued to monitor geopolitical headlines and commodity developments as they assess potential impacts on corporate costs and earnings trajectories into the trading day.